SCHEMBL2179877

SCHEMBL2179877

CC(C)C(C(=O)O)N1Cc2ccc(Br)cc2C1=O

nearest known ligand 0.62

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SDCBP O00560 5/20 0.62
SDC2 P34741 5/20 0.62
VHL P40337 3/20 0.42
LMNA P02545 3/20 0.42
THRB P10828 1/20 0.42
TP53 P04637 1/20 0.41
ALOX15 P16050 3/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 1/20 0.41
TSHR P16473 1/20 0.41
XIAP P98170 1/20 0.41
HKDC1 Q2TB90 1/20 0.41
HSD17B10 Q99714 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2181199 0.89 SDCBP (0.76) SDCBPSDC2VHLLMNATHRB
SCHEMBL21612919 0.89 SDCBP (0.76) SDCBPSDC2VHLLMNATHRB
SCHEMBL20294842 0.88 SDCBP (0.52) SDCBPSDC2LMNATHRBTP53
SCHEMBL20294843 0.88 SDCBP (0.52) SDCBPSDC2LMNATHRBTP53
SCHEMBL18765504 0.86 SDCBP (0.52) SDCBPSDC2THRBALOX15MAPT
SCHEMBL18765599 0.86 SDCBP (0.52) SDCBPSDC2THRBALOX15MAPT
SCHEMBL2179112 0.86 SDCBP (0.52) SDCBPSDC2THRBALOX15MAPT
SCHEMBL15111834 0.82 LMNA (0.56) SDCBPSDC2LMNATHRBTP53
SCHEMBL2180875 0.82 SDCBP (0.51) SDCBPSDC2LMNATHRBALOX15
SCHEMBL18765807 0.81 ALOX15 (0.50) SDCBPSDC2ALOX15MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8748426-B2 Inhibitors of diacylglycerol acyl transferase Piramal Enterprises Limited (IN) 2014-06-10 US disclosed
US-20120289505-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE Piramal Enterprises Limited (IN) 2012-11-15 US disclosed
EP-2519500-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE Piramal Healthcare Ltd. (IN) 2012-11-07 EP disclosed
WO-2011080718-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE PIRAMAL LIFE SCIENCES LIMITED (IN) 2011-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120289505-A1 INHIBITORS OF DIACYLGLYCEROL ACYL TRANSFERASE DGAT1, DGAT2, LCAT SDCBP 2373/4885SDC2 3855/4885VHL 3376/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.